GL1X · GenesisL1 explorer

Research workbench

The catalytic domain of murine urokinase-type plasminogen activator in complex with the active site binding inhibitory nanobody NB22

Analyse The catalytic domain of murine urokinase-type plasminogen activator in complex… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5LHR
Type
protein
Length
361 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Urokinase-type plasminogen activator; Camelid-derived antibody fragment NB22
EC
3.4.21.73
UniProt
P06869
Pockets
2 · best druggability 0.50

Structure

x-ray diffraction · 2 distinct chains · 8% helix, 43% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AUrokinase-type plasminogen activator (EC 3.4.21.73)protein24510% helix, 40% strandP06869
BCamelid-derived antibody fragment NB22protein1165% helix, 48% strand—

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12270.500.7546empty
2560.380.8018empty

Interfaces

1 interface between chains.

  • A–B · 915 Ų buried · 28 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 6 disulfide (disulfide).

Compared structures

  • 5LHR · The catalytic domain of murine urokinase-type plasminogen activator in complex with the… · the same entry in another collection · chain A against A, TM-score 1.00
  • P06869 · AlphaFold monomer V2.0 prediction for urokinase-type plasminogen activator (P06869) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.